Targeting Epigenetically Deregulated miRNA by Nutraceuticals: Focusing on Cancer Prevention and Treatment

Current Pharmacology Reports - Switzerland
doi 10.1007/s40495-015-0016-z
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Springer Science and Business Media LLC

Related search

Delivery of Antiinflammatory Nutraceuticals by Nanoparticles for the Prevention and Treatment of Cancer

Biochemical Pharmacology
BiochemistryPharmacology
2010English

Prevention and Treatment of Atherosclerosis: The Use of Nutraceuticals and Functional Foods

Handbook of Experimental Pharmacology
BiochemistryToxicologyPharmaceuticsPharmacology
2019English

Epigenetically Deregulated miR-200c Is Involved in a Negative Feedback Loop With DNMT3a in Gastric Cancer Cells

Oncology Reports
MedicineCancer ResearchOncology
2016English

Targeting Inflammation-Induced Obesity and Metabolic Diseases by Curcumin and Other Nutraceuticals

Annual Review of Nutrition
MedicineNutritionDietetics
2010English

Targeting Pre-miRNA by Peptide Nucleic Acids

Artificial DNA: PNA and XNA
MedicineBiochemistryOrganic Chemistry
2012English

Treatment of Cancer Pain by Targeting Cytokines

Mediators of Inflammation
ImmunologyCell Biology
2015English

Cancer Diagnostics, Imaging and Treatment by Nanoscale Structures Targeting

Biotechnologia Acta
2019English

miRNA‑222 Promotes Liver Cancer Cell Proliferation, Migration and Invasion and Inhibits Apoptosis by Targeting BBC3

International Journal of Molecular Medicine
MedicineGenetics
2018English

miRNA-145 Inhibits Non-Small Cell Lung Cancer Cell Proliferation by Targeting C-Myc

Journal of Experimental and Clinical Cancer Research
Cancer ResearchOncology
2010English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy